Literature DB >> 30003360

Timing of surgery in ulcerative colitis in the biologic therapy era-the patient's perspective.

Jörn Gröne1,2, Eva-Maria Lorenz1, Claudia Seifarth1, Hendrik Seeliger1, Martin E Kreis1, Mario H Mueller3.   

Abstract

BACKGROUND: There is no general consensus regarding the ideal timing of surgery in patients with refractory ulcerative colitis (UC). Decision-making and timing of restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is influenced by treating physicians and patients themselves. The aim of this study was to determine whether or not patients would have preferred the operation to be performed earlier, at the same time, or at a later point of time and to determine the reasons for their preference.
METHODS: Clinical data of 193 patients with UC who have undergone IPAA were documented in a prospective database at our institution between 2004 and 2015. From this database, 190 patients were identified and a standardized custom-made questionnaire was mailed for follow-up survey. Patients who did not respond were called by telephone and encouraged to complete the questionnaire.
RESULTS: One hundred nine questionnaires were eligible for analysis (57.4%). Average time between diagnosis and surgery was 11.2 ± 10.8 years (mean ± SD). Indications for surgery were refractory disease (70.6%), colitis-associated colorectal cancer (11.0%), high-grade dysplasia or stenosis (11.9%), and septic complications of UC (6.4%); 39 of 77 patients (50.6%) with refractory UC reported to have preferred their operation to be carried out earlier as it was actually performed (16.8 ± 11.9 months). Refractory course of the disease was identified as a predictor for a retrospectively desired earlier surgical approach (p = 0.014).
CONCLUSION: A substantial proportion of patients felt that they should have undergone surgery earlier than actually performed. It appears that timing of the decision to undergo surgery is suboptimal. This situation may be improved by earlier surgical consultation in the course of the disease.

Entities:  

Keywords:  Patient’s perspective; Timing of surgery; Ulcerative colitis

Mesh:

Year:  2018        PMID: 30003360     DOI: 10.1007/s00384-018-3129-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  27 in total

1.  The correlation between quality of life and functional outcome in ulcerative colitis patients after proctocolectomy ileal pouch anal anastomosis.

Authors:  E Carmon; A Keidar; A Ravid; G Goldman; M Rabau
Journal:  Colorectal Dis       Date:  2003-05       Impact factor: 3.788

2.  Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis.

Authors:  K T Park; Raymond Tsai; Felipe Perez; Lauren E Cipriano; Dorsey Bass; Alan M Garber
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

Review 3.  Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data.

Authors:  Meenakshi Bewtra; F Reed Johnson
Journal:  Patient       Date:  2013       Impact factor: 3.883

4.  Patient-centered informed consent in surgical practice.

Authors:  James L Bernat; Lynn M Peterson
Journal:  Arch Surg       Date:  2006-01

5.  Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients.

Authors:  Victor Warren Fazio; Ravi P Kiran; Feza H Remzi; John Calvin Coffey; Helen Mary Heneghan; Hasan Tarik Kirat; Elena Manilich; Bo Shen; Sean T Martin
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

6.  Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis.

Authors:  C K Porter; M Welsh; M S Riddle; C Nieh; E J Boyko; G Gackstetter; T I Hooper
Journal:  Aliment Pharmacol Ther       Date:  2017-02-23       Impact factor: 8.171

7.  Patient preferences for surgical versus medical therapy for ulcerative colitis.

Authors:  Meenakshi Bewtra; Vikram Kilambi; Angelyn O Fairchild; Corey A Siegel; James D Lewis; F Reed Johnson
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

8.  Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.

Authors:  Amy L Lightner; Laura E Raffals; Kellie L Mathis; Robert R Cima; Chung Sang Tse; John H Pemberton; Eric J Dozois; Edward V Loftus
Journal:  J Crohns Colitis       Date:  2016-08-19       Impact factor: 9.071

9.  A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study.

Authors:  Jessica N Cohan; Elissa M Ozanne; Justin L Sewell; Rebecca K Hofer; Uma Mahadevan; Madhulika G Varma; Emily Finlayson
Journal:  Dis Colon Rectum       Date:  2016-06       Impact factor: 4.585

10.  Patients newly diagnosed with ulcerative colitis receive earlier treatment in surgical clinics.

Authors:  S T Ward; K K Li; P J Trivedi; R K Hejmadi; N Suggett; T Iqbal; T Ismail
Journal:  Colorectal Dis       Date:  2013-07       Impact factor: 3.788

View more
  2 in total

1.  Impact of preoperative duration of ulcerative colitis on long-term outcomes of restorative proctocolectomy.

Authors:  Olga A Lavryk; Luca Stocchi; Tracy L Hull; Jeremy M Lipman; Sherief Shawki; Stefan D Holubar; Conor P Delaney; Scott R Steele
Journal:  Int J Colorectal Dis       Date:  2019-11-23       Impact factor: 2.571

2.  Timing of Surgery to Treat Ulcerative Colitis: An Investigation Focused on Japanese Adults.

Authors:  Saki Yamada; Hitoshi Kameyama; Kaoru Abe; Kana Tanaka; Hidehito Oyanagi; Yosuke Tajima; Masato Nakano; Yoshifumi Shimada; Jun Sakata; Toshifumi Wakai
Journal:  Inflamm Intest Dis       Date:  2020-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.